Centene Corp (CNC)
75.58
+0.44
(+0.59%)
USD |
NYSE |
May 07, 11:36
Centene Enterprise Value: 38.54B for May 6, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 06, 2024 | 38.54B |
May 03, 2024 | 38.36B |
May 02, 2024 | 38.11B |
May 01, 2024 | 37.00B |
April 30, 2024 | 37.43B |
April 29, 2024 | 37.84B |
April 26, 2024 | 37.93B |
April 25, 2024 | 38.83B |
April 24, 2024 | 39.10B |
April 23, 2024 | 39.12B |
April 22, 2024 | 38.98B |
April 19, 2024 | 38.75B |
April 18, 2024 | 38.00B |
April 17, 2024 | 37.06B |
April 16, 2024 | 37.20B |
April 15, 2024 | 37.44B |
April 12, 2024 | 36.38B |
April 11, 2024 | 36.87B |
April 10, 2024 | 37.19B |
April 09, 2024 | 37.44B |
April 08, 2024 | 37.58B |
April 05, 2024 | 37.48B |
April 04, 2024 | 37.09B |
April 03, 2024 | 37.62B |
April 02, 2024 | 37.30B |
Date | Value |
---|---|
April 01, 2024 | 40.14B |
March 31, 2024 | 40.53B |
March 28, 2024 | 40.27B |
March 27, 2024 | 40.20B |
March 26, 2024 | 39.78B |
March 25, 2024 | 39.52B |
March 22, 2024 | 39.44B |
March 21, 2024 | 39.58B |
March 20, 2024 | 39.95B |
March 19, 2024 | 40.39B |
March 18, 2024 | 39.49B |
March 15, 2024 | 38.66B |
March 14, 2024 | 38.97B |
March 13, 2024 | 39.33B |
March 12, 2024 | 39.34B |
March 11, 2024 | 40.03B |
March 08, 2024 | 40.09B |
March 07, 2024 | 40.90B |
March 06, 2024 | 39.79B |
March 05, 2024 | 39.69B |
March 04, 2024 | 40.18B |
March 01, 2024 | 40.00B |
February 29, 2024 | 40.24B |
February 28, 2024 | 40.22B |
February 27, 2024 | 41.30B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
17.45B
Minimum
Sep 26 2019
59.37B
Maximum
Aug 15 2022
40.21B
Average
40.38B
Median
Enterprise Value Benchmarks
The Cigna Group | 120.66B |
Molina Healthcare Inc | 13.35B |
UnitedHealth Group Inc | 500.34B |
Elevance Health Inc | 113.96B |
CVS Health Corp | 121.50B |
Enterprise Value Related Metrics
Net Income (Quarterly) | 1.163B |
Revenue (Quarterly) | 40.41B |
Total Expenses (Quarterly) | 39.29B |
EPS Diluted (Quarterly) | 2.16 |
Gross Profit Margin (Quarterly) | 11.50% |
Profit Margin (Quarterly) | 2.88% |
Earnings Yield | 6.66% |
Operating Earnings Yield | 8.16% |
Normalized Earnings Yield | 4.558 |